{"component": "definition", "props": {"groups": [{"samples": [{"hash": "vOKym3oxGg", "uri": "/contracts/vOKym3oxGg#other-active", "label": "License Agreement (Larkspur Health Acquisition Corp.)", "score": 33.7364807129, "published": true}, {"hash": "KyCgt2EA1q", "uri": "/contracts/KyCgt2EA1q#other-active", "label": "License Agreement (Tonix Pharmaceuticals Holding Corp.)", "score": 32.3538665771, "published": true}, {"hash": "evZGvE7nOD0", "uri": "/contracts/evZGvE7nOD0#other-active", "label": "License Agreement (Chimerix Inc)", "score": 30.8425731659, "published": true}], "size": 19, "snippet": "means any active pharmaceutical ingredient that is not a Compound.", "snippet_links": [{"key": "active-pharmaceutical-ingredient", "type": "clause", "offset": [10, 42]}], "hash": "42d86df53980457434c0911de77c4196", "id": 1}, {"samples": [{"hash": "7Ht1zXqtgBH", "uri": "/contracts/7Ht1zXqtgBH#other-active", "label": "Joint Venture, Research Collaboration and License Agreement (Arcturus Therapeutics Ltd.)", "score": 30.270362854, "published": true}, {"hash": "jqmaCGwvtPV", "uri": "/contracts/jqmaCGwvtPV#other-active", "label": "Joint Venture, Research Collaboration and License Agreement (Arcturus Therapeutics Ltd.)", "score": 30.2073917389, "published": true}, {"hash": "hWoVM7ssJVJ", "uri": "https://ir.arcturusrx.com/static-files/9da93985-c8e4-42f7-9e47-ad22695fabfb", "label": "ir.arcturusrx.com", "score": 9.9938402176, "published": false}], "size": 6, "snippet": "means any active pharmaceutical ingredient that is not a Collaboration Compound.", "snippet_links": [{"key": "active-pharmaceutical-ingredient", "type": "clause", "offset": [10, 42]}, {"key": "collaboration-compound", "type": "definition", "offset": [57, 79]}], "hash": "7f61d2760d69c628b432e61611dc4d56", "id": 2}, {"samples": [{"hash": "7hlbq9lfKYL", "uri": "/contracts/7hlbq9lfKYL#other-active", "label": "Option and License Agreement", "score": 31.3408622742, "published": true}, {"hash": "kBbZ7UPK36x", "uri": "/contracts/kBbZ7UPK36x#other-active", "label": "Option and License Agreement (Arsanis, Inc.)", "score": 28.8001365662, "published": true}, {"hash": "iOA4NQPhoD7", "uri": "/contracts/iOA4NQPhoD7#other-active", "label": "Option and License Agreement (Arsanis, Inc.)", "score": 28.7180023193, "published": true}], "size": 4, "snippet": "means any active therapeutic ingredient other than a Licensed Antibody.", "snippet_links": [{"key": "licensed-antibody", "type": "definition", "offset": [53, 70]}], "hash": "bdcf7ddd49781b01b7bf4266c3a99de2", "id": 3}, {"samples": [{"hash": "57xHOhAXI9I", "uri": "/contracts/57xHOhAXI9I#other-active", "label": "Option and License Agreement", "score": 31.3408622742, "published": true}, {"hash": "bonT3i9HHEY", "uri": "/contracts/bonT3i9HHEY#other-active", "label": "Option and License Agreement (Arcus Biosciences, Inc.)", "score": 29.1259403229, "published": true}, {"hash": "2IWhGbjg3UZ", "uri": "/contracts/2IWhGbjg3UZ#other-active", "label": "Option and License Agreement (Arcus Biosciences, Inc.)", "score": 29.049282074, "published": true}], "size": 4, "snippet": "means, with respect to a Combination Product, any active pharmaceutical ingredient other than a particular Antibody or Compound within such Combination Product. It is understood that an Other Active may be another Antibody or Compound.", "snippet_links": [{"key": "with-respect-to", "type": "clause", "offset": [7, 22]}, {"key": "combination-product", "type": "clause", "offset": [25, 44]}, {"key": "active-pharmaceutical-ingredient", "type": "clause", "offset": [50, 82]}], "hash": "68fd5407e39d3883c39e8b823a39dfdb", "id": 4}, {"samples": [{"hash": "8c7XPajBPrj", "uri": "/contracts/8c7XPajBPrj#other-active", "label": "Collaboration and License Agreement (Equillium, Inc.)", "score": 34.6016426086, "published": true}, {"hash": "cFQRjnTgpr", "uri": "/contracts/cFQRjnTgpr#other-active", "label": "Collaboration and License Agreement (Equillium, Inc.)", "score": 29.7091026306, "published": true}, {"hash": "b8Un5ZAfayp", "uri": "/contracts/b8Un5ZAfayp#other-active", "label": "Collaboration and License Agreement (Equillium, Inc.)", "score": 29.585899353, "published": true}], "size": 3, "snippet": "means any active pharmaceutical ingredient other than ITO.", "snippet_links": [{"key": "active-pharmaceutical-ingredient", "type": "clause", "offset": [10, 42]}], "hash": "a717ca1879a300aa3c4d24e0f33f1013", "id": 5}, {"samples": [{"hash": "5O73xV4pYtp", "uri": "/contracts/5O73xV4pYtp#other-active", "label": "Asset Purchase Agreement (Eton Pharmaceuticals, Inc.)", "score": 30.3442840576, "published": true}, {"hash": "dW0OmlAI7Gj", "uri": "http://pdf.secdatabase.com/2306/0001493152-19-006526.pdf", "label": "pdf.secdatabase.com", "score": 20.527721405, "published": false}, {"hash": "6zK9ucAU0ME", "uri": "https://ir.etonpharma.com/static-files/a7cada3f-e4e9-4e1b-804f-a73569eec5ce", "label": "ir.etonpharma.com", "score": 9.9938402176, "published": false}], "size": 3, "snippet": "means any active pharmaceutical ingredient other than [* * *].", "snippet_links": [{"key": "active-pharmaceutical-ingredient", "type": "clause", "offset": [10, 42]}], "hash": "191560c5c2585694a8efc730563f0eca", "id": 6}, {"samples": [{"hash": "ddv9aqjUJhY", "uri": "/contracts/ddv9aqjUJhY#other-active", "label": "License and Technology Transfer Agreement (Cidara Therapeutics, Inc.)", "score": 35.6146469116, "published": true}, {"hash": "dHT6Tcb0GlJ", "uri": "/contracts/dHT6Tcb0GlJ#other-active", "label": "Exclusive License and Collaboration Agreement (Cidara Therapeutics, Inc.)", "score": 32.3620796204, "published": true}, {"hash": "6B9cAy01AVw", "uri": "https://ir.cidara.com/static-files/66080cc4-4c7c-4a5f-8cd9-ce7ac4794c37", "label": "ir.cidara.com", "score": 10.6810407639, "published": false}], "size": 3, "snippet": "means any active pharmaceutical ingredient that is not a Compound or a product containing any such active pharmaceutical ingredient (and not containing a Compound). For clarity, drug delivery vehicles, [***] and excipients are hereby deemed not to be \u201cOther Actives.\u201d", "snippet_links": [{"key": "active-pharmaceutical-ingredient", "type": "clause", "offset": [10, 42]}, {"key": "for-clarity", "type": "clause", "offset": [165, 176]}, {"key": "delivery-vehicles", "type": "clause", "offset": [183, 200]}, {"key": "other-actives", "type": "definition", "offset": [252, 265]}], "hash": "403ed9bf3f1e4e4a4333a38556cf3f5c", "id": 7}, {"samples": [{"hash": "c6hJsqEspTb", "uri": "/contracts/c6hJsqEspTb#other-active", "label": "License Agreement (Jazz Pharmaceuticals PLC)", "score": 32.1457901001, "published": true}, {"hash": "7vITJDWZEyj", "uri": "/contracts/7vITJDWZEyj#other-active", "label": "License Agreement (Jazz Pharmaceuticals PLC)", "score": 31.0561256409, "published": true}], "size": 2, "snippet": "means any active pharmaceutical ingredient other than Licensed API.", "snippet_links": [{"key": "active-pharmaceutical-ingredient", "type": "clause", "offset": [10, 42]}, {"key": "licensed-api", "type": "definition", "offset": [54, 66]}], "hash": "7368a8dddae12fa92ea3614eb0d0f62d", "id": 8}, {"samples": [{"hash": "37fFpuHzHnP", "uri": "/contracts/37fFpuHzHnP#other-active", "label": "Assignment and License Agreement (Adagio Therapeutics, Inc.)", "score": 32.5373039246, "published": true}, {"hash": "9U1Nj8bnPRV", "uri": "https://investors.adagiotx.com/static-files/04bebec1-8d8a-448d-b13f-fb03db0eac58", "label": "Amendment", "score": 14.7700204849, "published": false}], "size": 2, "snippet": "means any active therapeutic ingredient other than a CoV Antibody.", "snippet_links": [], "hash": "c48b1dca579ba35d86734bbb95991e7c", "id": 9}, {"samples": [{"hash": "HtOKd51iDi", "uri": "/contracts/HtOKd51iDi#other-active", "label": "License Agreement (Dermavant Sciences LTD)", "score": 28.3908290863, "published": true}, {"hash": "fHL7JgTUSGo", "uri": "/contracts/fHL7JgTUSGo#other-active", "label": "License Agreement (Dermavant Sciences LTD)", "score": 28.1882266998, "published": true}], "size": 2, "snippet": "means any Active Pharmaceutical Ingredient that is not a Muscarinic Modulator.", "snippet_links": [{"key": "active-pharmaceutical-ingredient", "type": "clause", "offset": [10, 42]}], "hash": "cb63509ba3af84392810cce6115c71c2", "id": 10}], "next_curs": "ClkSU2oVc35sYXdpbnNpZGVyY29udHJhY3RzcjULEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiIVb3RoZXItYWN0aXZlIzAwMDAwMDBhDKIBAmVuGAAgAA==", "definition": {"size": 60, "title": "Other Active", "snippet": "means any active pharmaceutical ingredient that is not a Compound.", "id": "other-active", "examples": ["Net Sales of a Licensed Product that is a Combination Product that includes an Antibody or a Compound from more than one Arcus Program shall be allocated to the applicable Arcus Program in accordance with the provisions in the definition of Net Sales with respect to Combination Products (i.e., mutatis mutandis, treating the Antibody or Compound from such other Arcus Program as an <strong>Other Active</strong>).", "Except as expressly provided herein, Licensor grants no other right or license, including any rights or licenses to the Licensor Background Patents, the Licensor Program Patents, the Licensor Background Know-How, the Licensor Program Know-How, the Regulatory Documentation, the Licensor Corporate Names, or any other Patent, <strong>Other Active</strong> Ingredient or intellectual property rights not otherwise expressly granted herein.", "In the event the feasibility of using ** or ** (each, an \u201c<strong>Other Active</strong> Agent\u201d) with the Formulation in the Field is demonstrated under a separate agreement between SurModics and Edge, then the meaning of the term Active Agent shall be expanded to include such <strong>Other Active</strong> Agent (or both, as the case may be) (the \u201cActive Agent Option\u201d).", "Notwithstanding anything in the foregoing, in no event shall any rights or licenses granted in this Section 10.3.2 apply to any <strong>Other Active</strong> Ingredient in a Licensed Product that is a Combination Product and in no event shall Sionna provide AbbVie any right to Exploit any <strong>Other Active</strong> Ingredient.", "Notwithstanding the provisions of Section 10.1(b), any Inventions directed solely and specifically to any Licensed API or Licensed Product in combination with any <strong>Other Active</strong>, other than a Joint Specific Combination Invention, shall be deemed a \u201cSpecific Combination Invention\u201d.", "Notwithstanding anything to the contrary, AbbVie grants no right or license with respect to <strong>Other Active</strong> Ingredients.", "Notwithstanding the provisions of Section 10.1(b), any Inventions directed solely and specifically to any Licensed API or Licensed Product in combination with any <strong>Other Active</strong> that is covered by Patent Rights owned by or licensed to Jazz or its Affiliates (a \u201cJazz Proprietary Component\u201d) shall be deemed a \u201cJoint Specific Combination Invention\u201d.", "The parties agree that each Product incorporating an <strong>Other Active</strong> Agent (and each unique combination of Active Agents) shall be considered separate Products and shall require payment of all the enumerated Milestones in Section 4 as the new Product meets the enumerated Milestones with the exception of the Initial Milestone due upon execution of this Agreement and no credit will be given for previously paid Milestone amounts.", "Notwithstanding anything to the contrary, AbbVie grants no right or license with respect to <strong>Other Active</strong> Ingredients owned or controlled by AbbVie or its Affiliates.", "Without limiting Section 5.2.2 and Section 5.2.3, Licensee shall use reasonable efforts to file separately Patents claiming any Licensee-owned invention that is necessary or useful for the development, manufacture, use or sale of any compound (including any <strong>Other Active</strong>) that is not a Licensed Compound or any product that is not a Licensed Product."], "related": [["other-actions", "Other Actions", "Other Actions"], ["activity", "Activity", "Activity"], ["activities", "Activities", "Activities"], ["program-or-activity", "Program or activity", "Program or activity"], ["intrascholastic-activities", "Intrascholastic Activities", "Intrascholastic Activities"]], "related_snippets": [], "updated": "2026-09-04T04:26:51+00:00"}, "json": true, "cursor": ""}}